AIMS: Left bundle branch block (LBBB) is a critical predictor of patient benefit from cardiac resynchronization therapy (CRT), but recent studies suggest that one-third of patients diagnosed with LBBB by conventional electrocardiographic (ECG) criteria may have a false-positive diagnosis. In this study, we tested the hypothesis that recently proposed strict LBBB ECG criteria improve specificity in cases of left ventricular hypertrophy (LVH) /dilatation and incomplete LBBB. METHODS AND RESULTS: We developed five heart models based on a healthy male with increasing degrees of LV hypertrophy and/or dilation. With each model, we simulated six conduction types: normal conduction, four increments of delayed initiation of LV activation (incomplete LBBB), and complete LBBB. Simulated ECGs were evaluated for the presence of LBBB by conventional (LV conduction delay and QRSd ≥120 ms) and strict ECG criteria (LV conduction delay, QRSd ≥140 ms men or ≥130 ms women, and mid-QRS notching in at least two of the leads I, aVL, V1, V2, V5, and/or V6). Both conventional and strict LBBB criteria had 100% sensitivity. However, conventional criteria falsely diagnosed LBBB in cases with LVH + LV dilated 10 mm, LVH or LV dilated 10 mm combined with LV initiation ≥6 ms after the right ventricle (RV), and with LV dilated 5 mm combined with LV initiation ≥12 ms after RV (48% specificity). Strict LBBB criteria resulted in no false positives (100% specificity). CONCLUSIONS: New strict LBBB criteria increase the specificity of complete LBBB diagnosis in the presence of LV hypertrophy/dilatation and incomplete LBBB, which is critical for selecting CRT patients.
AIMS: Left bundle branch block (LBBB) is a critical predictor of patient benefit from cardiac resynchronization therapy (CRT), but recent studies suggest that one-third of patients diagnosed with LBBB by conventional electrocardiographic (ECG) criteria may have a false-positive diagnosis. In this study, we tested the hypothesis that recently proposed strict LBBB ECG criteria improve specificity in cases of left ventricular hypertrophy (LVH) /dilatation and incomplete LBBB. METHODS AND RESULTS: We developed five heart models based on a healthy male with increasing degrees of LV hypertrophy and/or dilation. With each model, we simulated six conduction types: normal conduction, four increments of delayed initiation of LV activation (incomplete LBBB), and complete LBBB. Simulated ECGs were evaluated for the presence of LBBB by conventional (LV conduction delay and QRSd ≥120 ms) and strict ECG criteria (LV conduction delay, QRSd ≥140 ms men or ≥130 ms women, and mid-QRS notching in at least two of the leads I, aVL, V1, V2, V5, and/or V6). Both conventional and strict LBBB criteria had 100% sensitivity. However, conventional criteria falsely diagnosed LBBB in cases with LVH + LV dilated 10 mm, LVH or LV dilated 10 mm combined with LV initiation ≥6 ms after the right ventricle (RV), and with LV dilated 5 mm combined with LV initiation ≥12 ms after RV (48% specificity). Strict LBBB criteria resulted in no false positives (100% specificity). CONCLUSIONS: New strict LBBB criteria increase the specificity of complete LBBB diagnosis in the presence of LV hypertrophy/dilatation and incomplete LBBB, which is critical for selecting CRT patients.
Entities:
Keywords:
Cardiac resynchronization therapy; Electrocardiography; Left bundle branch block; Simulations
Authors: A W Maurits van der Graaf; Pranav Bhagirath; Vincent J H M van Driel; Hemanth Ramanna; Jacques de Hooge; Natasja M S de Groot; Marco J W Götte Journal: Ann Noninvasive Electrocardiol Date: 2014-07-17 Impact factor: 1.468
Authors: Saara Sillanmäki; Jukka A Lipponen; Mika P Tarvainen; Tiina Laitinen; Marja Hedman; Antti Hedman; Antti Kivelä; Hanna Hämäläinen; Tomi Laitinen Journal: J Nucl Cardiol Date: 2018-02-08 Impact factor: 5.952
Authors: Xiaojuan Xia; Anne-Christine Ruwald; Martin H Ruwald; Nene Ugoeke; Barbara Szepietowska; Valentina Kutyifa; Mehmet K Aktas; Poul Erik B Thomsen; Wojciech Zareba; Arthur J Moss; Jean-Philippe Couderc Journal: Ann Noninvasive Electrocardiol Date: 2016-08-30 Impact factor: 1.468
Authors: Loek P B Meijs; Loriano Galeotti; Esther P Pueyo; Daniel Romero; Robert B Jennings; Michael Ringborn; Stafford G Warren; Galen S Wagner; David G Strauss Journal: Am J Physiol Heart Circ Physiol Date: 2014-04-28 Impact factor: 4.733
Authors: Dulciana D Chan; Katherine C Wu; Zak Loring; Loriano Galeotti; Gary Gerstenblith; Gordon Tomaselli; Robert G Weiss; Galen S Wagner; David G Strauss Journal: Am J Cardiol Date: 2014-03-02 Impact factor: 2.778